Benzinga | Feb 25, 2021 04:25PM EST

Apellis Pharmaceuticals Q4 EPS $0.93 Up From $(1.77) YoY, Sales $250.00M May Not Compare To $96.09M Estimate

Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly earnings of $0.93 per share. This is a 152.54 percent increase over losses of $(1.77) per share from the same period last year. The company reported quarterly sales of $250.00 million which beat the analyst consensus estimate of $96.09 million by 160.17 percent.